DutchNews.NL20 分钟
Agendia Announces Publication Validating MammaPrint® Utility in Prediction of Extended ...
A secondary analysis of the randomized controlled trial, IDEAL, confirms results from NSABP B-42 demonstrating MammaPrint is ...